Full name
NEURO-CARE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
86.10.Z - Hospital activities
72.19.Z - Other research and experimental development on natural sciences and engineering
86.22.Z - Specialist medical practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
87.20.Z - Residential care activities for mental retardation, mental health and substance abuse
93.13.Z - Operation of fitness facilities
96.04.Z - Physical well-being activities
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 0,1 | 0,7 | 932,3 |
EBITDA | 0,8 | 0,1 | 0,7 | 537,2 |
Short time liabilities | 0,3 | 0,2 | 0,3 | 35,5 |
Equity capital | 0,5 | 0,6 | 1,3 | 114,8 |
Operating profit (EBIT) | 0,8 | 0,1 | 0,7 | 828,1 |
Assets | 1,1 | 1,4 | 2 | 40,8 |
Net profit (loss) | 0,8 | 0,1 | 0,7 | 883,4 |
Cash | 0,3 | 0,6 | 0,7 | 33,2 |
Net income from sale | 4,3 | 1,7 | 1,8 | 2,5 |
Liabilities and provisions for liabilities | 0,6 | 0,8 | 0,7 | -14,4 |
Working assets | 1 | 1,3 | 1,9 | 45 |
Depreciation | 0 | 0 | 0 | -25,6 |
% | % | % | p.p. | |
Profitability of capital | 143,3 | 11,7 | 53,4 | 41,7 |
Equity capital to total assets | 47,1 | 42,8 | 65,2 | 22,4 |
Gross profit margin | 17,4 | 4 | 40 | 36 |
EBITDA Margin | 19,1 | 6,6 | 41 | 34,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 26 | 42 | 56 | 14 |
Current financial liquidity indicator | 3.2967538833618164 | 6.360355377197266 | 6.835415363311768 | 0,4 |
Net dept to EBITDA | 0.028543924912810326 | 0.3097645342350006 | -0.4562493562698364 | -0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane